Index RUT P/E - EPS (ttm) -1.72 Insider Own 3.70% Shs Outstand 56.32M Perf Week 6.74%
Market Cap 1.37B Forward P/E - EPS next Y -0.83 Insider Trans 0.00% Shs Float 54.30M Perf Month -16.28%
Enterprise Value 1.16B PEG - EPS next Q -0.53 Inst Own 104.05% Short Float 12.89% Perf Quarter -27.00%
Income -95.57M P/S 4.43 EPS this Y 14.60% Inst Trans -2.06% Short Ratio 4.65 Perf Half Y -36.83%
Sales 308.05M P/B 3.73 EPS next Y 43.67% ROA -18.34% Short Interest 7.00M Perf YTD -23.01%
Book/sh 6.50 P/C 4.77 EPS next 5Y 37.00% ROE -24.89% 52W High 66.85 -63.77% Perf Year -60.02%
Cash/sh 5.08 P/FCF - EPS past 3/5Y 4.30% -7.02% ROIC -21.62% 52W Low 19.35 25.17% Perf 3Y -29.78%
Dividend Est. - EV/EBITDA - Sales past 3/5Y 60.14% 109.04% Gross Margin 62.66% Volatility 10.02% 7.62% Perf 5Y -
Dividend TTM - EV/Sales 3.76 EPS Y/Y TTM 2.21% Oper. Margin -33.71% ATR (14) 2.10 Perf 10Y -
Dividend Ex-Date - Quick Ratio 5.77 Sales Y/Y TTM 37.22% Profit Margin -31.02% RSI (14) 37.75 Recom 1.73
Dividend Gr. 3/5Y - - Current Ratio 6.85 EPS Q/Q -52.00% SMA20 -10.17% Beta 1.00 Target Price 32.92
Payout - Debt/Eq 0.21 Sales Q/Q 11.94% SMA50 -17.65% Rel Volume 1.61 Prev Close 25.35
Employees 888 LT Debt/Eq 0.21 Earnings Feb 25 AMC SMA200 -39.38% Avg Volume 1.50M Price 24.22
IPO Sep 15, 2021 Option/Short Yes / Yes EPS/Sales Surpr. -63.58% -18.54% Trades
Volume 2,414,700 Change -4.46%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-26 Initiated Robert W. Baird
Neutral
$30
Feb-26-26 Downgrade Oppenheimer
Outperform → Perform
Feb-26-26 Downgrade BofA Securities
Neutral → Underperform
$20
Dec-12-25 Initiated UBS
Buy
$62
Dec-08-25 Downgrade BofA Securities
Buy → Neutral
$38
Sep-02-25 Upgrade Oppenheimer
Perform → Outperform
$60
Jul-09-25 Initiated Stephens
Overweight
$70
Jul-07-25 Initiated Oppenheimer
Perform
Dec-02-24 Initiated Morgan Stanley
Overweight
$105
Nov-14-24 Initiated Jefferies
Hold
$95
Aug-11-23 Initiated Piper Sandler
Overweight
$42
May-31-23 Initiated William Blair
Outperform
Oct-31-22 Initiated BTIG Research
Neutral
Oct-25-22 Initiated Truist
Buy
$58
Sep-02-22 Initiated Wells Fargo
Overweight
$49
Jul-15-22 Initiated KeyBanc Capital Markets
Overweight
$47
Jun-23-22 Initiated B. Riley Securities
Buy
$53
Oct-11-21 Initiated SVB Leerink
Outperform
$46
Oct-11-21 Initiated Guggenheim
Buy
$45
Oct-11-21 Initiated Goldman
Neutral
$37
Show Previous Ratings
Mar-03-26 08:18AM
Mar-01-26 11:35AM
Feb-26-26 04:34PM
04:06PM
(Investor's Business Daily)
11:21AM
10:17AM
Loading…
10:17AM
08:30AM
07:55AM
07:04AM
02:11AM
12:04AM
Feb-25-26 07:25PM
04:02PM
Feb-24-26 10:20AM
Feb-23-26 04:03PM
07:23AM
Loading…
07:23AM
Feb-12-26 08:09AM
Feb-05-26 08:15AM
Feb-04-26 05:40PM
04:03PM
Jan-26-26 04:03PM
Jan-08-26 09:12AM
Jan-07-26 08:41AM
Dec-22-25 06:50AM
Dec-15-25 07:03AM
Nov-20-25 04:03PM
Nov-18-25 05:07AM
Nov-05-25 12:04AM
Nov-04-25 05:40PM
04:03PM
10:00AM
Loading…
Oct-30-25 10:00AM
Oct-29-25 09:00AM
Oct-28-25 10:00AM
Oct-20-25 11:08PM
09:20AM
Oct-15-25 04:03PM
Sep-15-25 09:01AM
Sep-04-25 06:13AM
Aug-27-25 08:29AM
Aug-21-25 12:30PM
11:15AM
Aug-13-25 12:08PM
Aug-06-25 05:45PM
04:03PM
Aug-05-25 08:15AM
Aug-04-25 05:45PM
Jul-31-25 10:30AM
Jul-30-25 10:00AM
Jul-25-25 07:00AM
Jul-24-25 06:00PM
Jul-23-25 08:00AM
Jul-21-25 04:03PM
Jul-14-25 09:15PM
Apr-29-25 04:03PM
Apr-24-25 04:03PM
02:37PM
08:15AM
07:00AM
Apr-10-25 04:03PM
Mar-29-25 06:03PM
Mar-24-25 08:00AM
Mar-20-25 09:05AM
Mar-14-25 08:00AM
Feb-26-25 09:32AM
(Thomson Reuters StreetEvents) +8.61%
02:15AM
Feb-25-25 05:25PM
04:02PM
01:22AM
Feb-13-25 02:10PM
Feb-07-25 08:00AM
Jan-16-25 12:00PM
Dec-28-24 04:59AM
Nov-29-24 11:15AM
Nov-26-24 04:05PM
Nov-07-24 12:00PM
Nov-01-24 02:27PM
(Investor's Business Daily)
Oct-29-24 08:43PM
12:00PM
11:56AM
(Investor's Business Daily)
03:03AM
Oct-28-24 05:41PM
(Investor's Business Daily) +32.33%
04:19PM
02:17PM
11:39AM
08:10AM
07:00AM
07:00AM
Oct-25-24 09:35AM
09:01AM
Oct-21-24 10:00AM
Oct-09-24 04:04PM
Oct-08-24 12:29PM
(Medical Device Network) +6.29%
Oct-07-24 04:04PM
Oct-05-24 06:04PM
Sep-25-24 09:01AM
Sep-23-24 09:03AM
Aug-30-24 05:57AM
Aug-28-24 04:03PM
Aug-22-24 01:05PM
09:12AM
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Nouri Alaleh Officer Mar 06 '26 Proposed Sale 23.70 6,892 163,353 Mar 06 04:19 PM Waters Kevin Officer Mar 06 '26 Proposed Sale 23.70 6,721 159,300 Mar 06 04:07 PM Desai Antal Rohit Director Aug 14 '25 Option Exercise 1.33 26,749 35,576 35,152 Aug 15 04:53 PM MOLL FREDERIC H Director Aug 13 '25 Buy 39.26 20,000 785,138 863,159 Aug 14 04:18 PM Nouri Alaleh EVP, CLO, CORP. SEC. Aug 14 '25 Option Exercise 4.52 11,000 49,720 72,473 Aug 14 04:15 PM Desai Antal Rohit Director Jun 10 '25 Sale 63.91 25,000 1,597,711 64,363 Jun 12 07:28 PM Desai Antal Rohit Director Jun 11 '25 Sale 63.38 25,000 1,584,525 39,363 Jun 12 07:28 PM Desai Antal Rohit Director Jun 12 '25 Sale 61.49 25,000 1,537,256 14,363 Jun 12 07:28 PM SHAM SHIBLAQ Officer Jun 06 '25 Proposed Sale 64.13 20,000 1,282,638 Jun 06 04:22 PM Shiblaq Hisham EVP, Chief Comm. Officer Jun 06 '25 Option Exercise 5.18 20,000 103,600 83,133 Jun 06 04:02 PM Shiblaq Hisham EVP, Chief Comm. Officer Jun 06 '25 Sale 64.13 20,000 1,282,637 63,133 Jun 06 04:02 PM Desai Antal Rohit Director Jun 05 '25 Sale 64.79 25,000 1,619,830 89,363 Jun 05 08:05 PM Desai Antal Rohit Director Jun 04 '25 Sale 61.02 25,000 1,525,556 114,363 Jun 05 08:05 PM Desai Antal Rohit Director Jun 03 '25 Sale 60.66 25,000 1,516,475 139,363 Jun 05 08:05 PM 222 DNA TRUST Director Jun 03 '25 Proposed Sale 57.94 150,000 8,691,000 Jun 03 04:24 PM Zadno Reza President, CEO May 09 '25 Option Exercise 7.27 13,759 100,028 186,829 May 13 04:59 PM Zadno Reza President, CEO Mar 18 '25 Sale 57.06 5,475 312,404 173,070 Mar 19 04:16 PM Waters Kevin EVP, CFO Mar 18 '25 Sale 57.06 733 41,825 107,991 Mar 19 04:15 PM Shiblaq Hisham EVP, Chief Comm. Officer Mar 18 '25 Sale 57.06 247 14,094 63,133 Mar 19 04:08 PM Nouri Alaleh EVP, CLO, CORP. SEC. Mar 18 '25 Sale 57.06 316 18,031 61,473 Mar 19 04:04 PM Zadno Reza Officer Mar 18 '25 Proposed Sale 57.06 5,475 312,404 Mar 18 07:20 PM Waters Kevin Officer Mar 18 '25 Proposed Sale 57.06 733 41,825 Mar 18 07:07 PM Shiblaq Hisham Officer Mar 18 '25 Proposed Sale 57.06 247 14,094 Mar 18 04:24 PM Nouri Alaleh Officer Mar 18 '25 Proposed Sale 57.06 316 18,031 Mar 18 04:03 PM
